Galectin-3 test could decrease the number of unnecessary surgical procedures

May 18, 2008

Testing potentially cancerous thyroid nodules for the presence of galectin-3 could substantially decrease the number of unnecessary surgical procedures, say authors of a paper published early Online in The Lancet Oncology.

Testing thyroid nodules for cancer is an inexact science--about 85% of nodules removed by surgery turn out to be benign. The standard method of assessing whether or not a lesion is malignant is to examine cells extracted by fine-needle aspiration. However, distinguishing between cancerous and non-cancerous thyroid cells on a morphological basis alone can be difficult. "The high prevalence of thyroid nodules in the adult population (19-67% of randomly selected individuals) and the low prevalence of thyroid cancers, makes the diagnosis of thyroid cancer difficult", say the authors. Galectin-3 is a lectin molecule that is not normally present in the cytoplasm of thyroid cells; when it is abnormally present, the protein can block cell death, triggering the development of cancer.

Armando Bartolazzi from St Andrea Hospital, Rome, Italy, and colleagues undertook a national study to assess whether testing for galectin-3 could differentiate between benign and malignant cells and therefore prevent unnecessary surgical procedures. They tested galectin-3 expression in 465 people scheduled for surgery to remove thyroid nodules that could not be determined by cytology as benign or malignant. Patients were enrolled in the study between June 1, 2003, and August 30, 2006; most were women (76%) and the mean age was 50 years (range 21 to 76 years). Individuals with thyroid nodules smaller than 1 cm in diameter were not enrolled.

After the nodules were removed, the final histological results that determined whether or not they had been cancerous were compared with the findings from galectin-3 testing.

Galectin-3 was not expressed in 331 (71%) of 465 nodules. 280 (85%) of these galactin-3-negative nodules turned out to be benign, but 29 (9%) were cancerous (the remaining 6% were borderline cases). Of these 29 false-negatives, 8 had a different galectin-3 expression in post-operative testing, suggesting that there might have been some technical problems in the testing (which the authors say could be improved upon with specific technical training).

The sensitivity of the test was 78% (95% CI 74-82) and specificity was 93% (90-95). The positive predictive value was 82% (789-86) and negative predictive value 91% (88-93).

The authors conclude: "The galectin-3 method proposed here does not replace conventional FNA-cytology, but represents a complementary diagnostic method for those follicular nodules that remain indeterminate. The correct approach for this preoperative characterisation of thyroid nodules always needs careful multidisciplinary assessment of each patient, according to published guidelines".
-end-
Dr Armando Bartolazzi, Department of Pathology, St Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy. Armando.Bartolazzi@ki.se T): +39-063 377 5321http://www.eurekalert.org/jrnls/lance/pdfs/TLOthyroidfinal.pdf

Lancet

Related Thyroid Nodules Articles from Brightsurf:

Thyroid inflammation linked to anxiety disorders
Patients with autoimmune inflammation of their thyroid may be at greater risk of developing anxiety, according to a study being presented at e-ECE 2020.

Some physicians are ordering thyroid tests for unsupported reasons
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.

Trends in the global burden of thyroid cancer
This study examined the worldwide trends of thyroid cancer from 1990 to 2017 according to geographic location, sex, age and socioeconomic factors.

Thyroid dysfunction in pregnancy being overdiagnosed, overtreated
The current practice of testing most pregnant women for thyroid stimulating hormone (TSH) may be leading to overdiagnosis and overtreatment, according to new research in CMAJ (Canadian Medical Association Journal). http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191664

Patients with COVID-19 may develop thyroid infection
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.

Artificial intelligence can categorize cancer risk of lung nodules
Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.

How nodules stay on top at the bottom of the sea
Rare metallic elements found in clumps on the deep-ocean floor mysteriously remain uncovered despite the shifting sands and sediment many leagues under the sea.

Thyroid cancer rates in US
An analysis suggests rates of thyroid cancer in the US appear to have plateaued in recent years after decades on the rise.

New radiomics model uses immunohistochemistry to predict thyroid nodules
American Journal of Roentgenology researchers have validated a first-of-its-kind machine learning-based model to evaluate immunohistochemical characteristics in patients with suspected thyroid nodules, achieving 'excellent performance' for individualized noninvasive prediction of the presence of cytokeratin 19, galectin 3, and thyroperoxidase based upon CT images.

Thyroid screening may not be needed in all youth with psychiatric disorders
A new study from researchers at the University of Cincinnati (UC) and Cincinnati Children's looks at the prevalence of abnormal thyroid function in youth with severe mood and anxiety disorder.

Read More: Thyroid Nodules News and Thyroid Nodules Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
Can't connect to localhost. Errorcode: 1203